FDA Clears KORU FreedomEDGE for RYSTIGGO Infusion
MAHWAH, N.J., January 29, 2026 — KORU Medical Systems has received U.S. FDA 510(k) clearance expanding the labeled use...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
MAHWAH, N.J., January 29, 2026 — KORU Medical Systems has received U.S. FDA 510(k) clearance expanding the labeled use...
UNITED STATES | January 27, 2026 — ABANZA, a medical technology company focused on advancing soft-tissue fixation solutions, announced...
CORONADO, CALIFORNIA | January 26, 2026 — Spine Innovation, LLC announced it has received FDA 510(k) clearance to market...
